Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$15.83 - $17.84 $468,568 - $528,064
-29,600 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$15.92 - $20.3 $43,238 - $55,134
-2,716 Reduced 8.4%
29,600 $508,000
Q4 2020

Feb 02, 2021

SELL
$15.65 - $19.92 $9,390 - $11,952
-600 Reduced 1.82%
32,316 $506,000
Q3 2020

Nov 05, 2020

BUY
$13.97 - $21.16 $18,161 - $27,508
1,300 Added 4.11%
32,916 $628,000
Q2 2020

Aug 12, 2020

BUY
$10.39 - $16.07 $27,024 - $41,798
2,601 Added 8.96%
31,616 $433,000
Q1 2020

May 12, 2020

SELL
$8.89 - $24.94 $37,400 - $104,922
-4,207 Reduced 12.66%
29,015 $308,000
Q4 2019

Jan 27, 2020

BUY
$8.33 - $19.95 $276,739 - $662,778
33,222 New
33,222 $620,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $118M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.